IL13RA2 and adrenal cortex carcinoma: Low IL-13Rα2 expression (n = 6) was associated with a 33% survival rate of ACC subjects with tumor metastasis while ACC subjects without metastatic tumors (n = 20) showed a 100% survival rate (p = .001).